true
Icon to close the modal
Support
Sales
Submit a form online
Go next / move forward Icon
Modal Close Icon
Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Customer Care
Contact Us
Go next / move forward Icon
Products

BD MaxPlus™ needle-free connector

Choose the only needle-free connector with an FDA-cleared label statement demonstrating a reduction in CLABSI

Contact Us
maxplus-needleless-connector_RC_VA_0517-0001
IV_0609_0155-carousel
maxplus-clear-needleless-connector_2_IV_0609_0163
Loading
Overview

Hospitals using the BD MaxPlus™ needle-free connector had lower unadjusted central line-associated bloodstream infection (CLABSI) rates, as well as lower standardised infection ratios, compared to hospitals not using the MaxPlus technology.*1

true
Features and Benefits
Ultrasound: It's what you are looking for

Solid sealed surface

The solid sealed surface withstands 7 days/200 activations.

MRI

Clear housing

The clear design shows the complete fluid pathway, enabling optimal visibility when flushing.

Versatile Applicator

No interstitial space

Zero interstitial space between the components limits opportunities for microbial ingress.

Zero-reflux action

Zero-reflux feature upon disconnection can help reduce catheter occlusions and catheter occlusions

EIFUs
true
Resources
events.svg
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
events.svg
Events

BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs.

Learn more
true

References

Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

* 2013 CMS hospital compare data from 3,074 hospitals, accounting for nearly 11,000 CLABSIs associated with nearly 10 million catheter days.

  1. Tabak YP, Johannes RS, Sun X, Crosby CT, Jarvis WR. Innovative use of existing public and private data sources for postmarket surveillance of central line-associated bloodstream infections associated with intravenous needleless connectors. J Infus Nurs. 2016;39(5):328-335.

BD-35577 (08/2021)

true